Mark A. Kay
Stanford University
H-index: 120
North America-United States
Top articles of Mark A. Kay
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors | Nature Biotechnology | Fabian P Suchy Daiki Karigane Yusuke Nakauchi Maimi Higuchi Jinyu Zhang | 2024/4/8 |
Recombinant adeno-associated virus capsids with enhanced human pancreatic tropism | 2019/8/20 | ||
Novel recombinant adeno-associated virus capsids with enhanced human pancreatic tropism | 2016/12/2 | ||
Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transfer | Molecular Therapy-Nucleic Acids | Francesco Puzzo Chuanling Zhang Bethany Powell Gray Feijie Zhang Bruce A Sullenger | 2023/3/14 |
Selection of viral capsids and promoters affects the efficacy of rescue of Tmprss3-deficient cochlea | Molecular Therapy-Methods & Clinical Development | Ksenia A Aaron Katja Pekrun Patrick J Atkinson Sara E Billings Julia M Abitbol | 2023/9/14 |
A standardized ontology for naming tRNA-derived RNAs based on molecular origin | Nature methods | Andrew D Holmes Patricia P Chan Qi Chen Pavel Ivanov Laurence Drouard | 2023/5 |
The AAV capsid can influence the epigenetic marking of rAAV delivered episomal genomes in a species dependent manner | Nature Communications | Adriana Gonzalez-Sandoval Katja Pekrun Shinnosuke Tsuji Feijie Zhang King L Hung | 2023/4/28 |
A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors | Frontiers in Immunology | Meredith E Davis-Gardner Jesse A Weber Jun Xie Katja Pekrun Eric A Alexander | 2023/4/21 |
Capsid-mediated chromatin state of the AAV vector genome controls host species range | bioRxiv | Adriana Gonzalez-Sandoval Shinnosuke Tsuji Feijie Zhang King L Hung Howard Y Chang | 2022/10/6 |
Using Recombinant Adeno-Associated Viral Vectors for Long-Term Expression of a Hyperactive Human Factor IX Mutant in Hemophilic Mice and Comparison of AAV-LK03 and AAV-KP1 in … | Anke Van der Perren Jaan Toelen Jean-Marc Taymans Veerle Baekelandt | 2012 | |
Methods And Compositions For Enhancing AAV-Mediated Homologous Recombination Using Ribonucleotide Reductase Inhibitors | 2022/9/1 | ||
Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal Mice | Frontiers in Genome Editing | Michela Lisjak Alessia De Caneva Thibaut Marais Elena Barbon Maria Grazia Biferi | 2022/3/11 |
Selective microvascular tissue transfection using Minicircle DNA for systemic delivery of human coagulation factor IX in a rat model using a therapeutic flap | Plastic and Reconstructive Surgery | Peter A Than Christopher R Davis Robert C Rennert Shane D Morrison Michael W Findlay | 2022/1/1 |
Evaluating the state of the science for adeno-associated virus integration: An integrated perspective | Denise E Sabatino Frederic D Bushman Randy J Chandler Ronald G Crystal Beverly L Davidson | 2022/8/3 | |
GATA4 regulates mitochondrial biogenesis and functions during cardiac development and rescues cardiac and mitochondrial functions impaired by TKIs | Qing Liu Haodi Wu Zhana Duren Chao Jiang Kevin Van Bortle | 2022/12/9 | |
Fludarabine increases nuclease-free AAV-and CRISPR/Cas9-mediated homologous recombination in mice | Nature biotechnology | Shinnosuke Tsuji Calvin J Stephens Giulia Bortolussi Feijie Zhang Gabriele Baj | 2022/8 |
Selection of rAAV vectors that cross the human blood-brain barrier and target the central nervous system using a transwell model | Molecular Therapy-Methods & Clinical Development | Ren Song Katja Pekrun Themasap A Khan Feijie Zhang Sergiu P Paşca | 2022/12/8 |
Non-disruptive gene targeting | 2022/6/30 | ||
Adeno-Associated Viral Vectors for Crossing the Human Blood Brain Barrier | 2022/12/1 | ||
Improved genome editing through inhibition of FANCM and members of the BTR dissolvase complex | Molecular Therapy | Gustavo de Alencastro Francesco Puzzo Mara Pavel-Dinu Feijie Zhang Sirika Pillay | 2021/3/3 |